• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does Carrying a Fetus with a Congenital Heart Defect Increase Preeclampsia Risk?

image_pdfFavoriteLoadingFavorite

PURPOSE:

An underlying mechanism for congenital heart defects includes abnormal vascular development, a phenomenon also linked with preeclampsia. This study by Boyd et al. (Circulation, 2017) sought to determine if having a fetus or newborn with a heart defect was similarly associated with a higher risk of hypertensive disorders during pregnancy.

METHODS:

Retrospective Cohort Study

RESULTS:

Data from 1,972,857 singleton pregnancies without chromosomal abnormalities ≥20 weeks gestation born in Denmark between 1978-2011, complicated by offspring with congenital heart defects and preeclampsia were analyzed. Congenital heart defects in offspring was most strongly associated with early preterm preeclampsia (odds ratio 7.00, 95% CI 6.11-8.03). Congenital heart defects were also associated with late term preterm preeclampsia (odds ratio 2.82, 95% CI 2.38-3.34) and less so with term preeclampsia (odds ratio 1.16, 95% CI 1.06-1.27)

However, congenital heart defects  were not associated with gestational hypertension (odds ratio 1.07, 95% CI 0.92-1.25). These results held regardless of type of congenital heart disease. The investigators also looked at congenital heart defects in offspring in a previous pregnancy as a predictor of preeclampsia in subsequent pregnancies and found similar associations: there was a risk for early preterm preeclampsia (odds ratio 2.37, 95% CI 1.68-3.34) and late preterm preeclampsia (odds ratio 2.04, 95% CI 1.52-2.75), minimal association with term preeclampsia, and no association with gestational hypertension.  When assessing preeclampsia in a previous pregnancy as a risk for congenital heart disease in subsequent pregnancies, preterm preeclampsia but not term preeclampsia or gestational hypertension was strongly associated with congenital heart defects in the offspring of later pregnancies (odds ratio 7.91, 95% CI 6.06-10.3). Late preterm preeclampsia was also associated with subsequent offspring with congenital heart disease (odds ratio 2.83, 95% CI 2.11-3.79) but term preeclampsia and gestational hypertension were not.  Because these associations appear to be present across multiple pregnancies, the authors suggest that the underlying pathophysiology is maternal and not fetal in origin.

Learn More – Primary Sources:

Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical obstetrics info for your women's healthcare practice
Tetralogy of Fallot- A Critical Congenital Heart Defect
Practical obstetrics info for your women's healthcare practice
Understanding Transposition of the Great Arteries
Practical obstetrics info for your women's healthcare practice
Hypoplastic Left Heart Syndrome – A Summary
Practical obstetrics info for your women's healthcare practice
Ventricular Septal Defect – Implications for the Fetus
Atrial Septal Defect (ASD) – Summary and Implications
Diagnosing Preeclampsia – Key Definitions and ACOG Guidelines

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site